NCT05934331 2025-09-12
A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study
LaNova Medicines Limited
Phase 2 Recruiting
LaNova Medicines Limited
The First Affiliated Hospital of Henan University of Science and Technology
Wuhan University
ChineseAMS